Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide o antigen

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4309-4316

  Gorgojo, Juan ^a   Lamberti, Yanina ^a   Valdez, Hugo ^a   Harvill, Eric T ^b   Rodríguez, Maria Eugenia ^a  

^a Universidad Nacional de La Plata   (Argentina)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE;

ARTICLE; BACTERICIDAL ACTIVITY; BORDETELLA PARAPERTUSSIS; COLONY FORMING UNIT; CONFOCAL MICROSCOPY; HOST CELL; HUMAN; HUMAN CELL; IMMUNITY; LIPID RAFT; LYSOSOME; NEUTROPHIL; NONHUMAN; NUTRIENT; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANTIBODIES, BACTERIAL; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; COLONY COUNT, MICROBIAL; HUMANS; MEMBRANE MICRODOMAINS; NEUTROPHILS; O ANTIGENS; OPSONIN PROTEINS; PHAGOCYTOSIS; WHOOPING COUGH;

EID: 84870806478     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00662-12     Document Type: Article

References (40)

1. Allen A, Maskell D. 1996. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol. Microbiol. 19:37!-52.
2. Allen AG, Thomas RM, Cadisch JT, Maskell DJ. 1998. Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol. Microbiol. 29:27-38.
3. Bokhari H, et al. 2011. Molecular typing of Bordetella parapertussis isolates circulating in Pakistan. FEMS Immunol. Med. Microbiol. 63:373-380.
4. Borska K, Simkovicova M. 1972. Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J. Hyg. Epidemiol. Microbiol. Immunol. 16:159-172.
5. Brockmeier SL, Register KB. 2000. Effect of temperature modulation and bvg mutation of Bordetella bronchiseptica on adhesion, intracellular survival and cytotoxicity for swine alveolar macrophages. Vet. Microbiol. 73:1-12.
6. Burns VC, Pishko EJ, Preston A, Maskell DJ, Harvill ET. 2003. Role of Bordetella O antigen in respiratory tract infection. Infect. Immun. 71:86-94.
7. Cherry JD, Seaton BL. 2012. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin. Infect. Dis. 54:534-537.
8. David S, van Furth R, Mooi FR. 2004. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine 22:1892-1898.
9. Goebel EM, Wolfe DN, Elder K, Stibitz S, Harvill ET. 2008. O antigen protects Bordetella parapertussis from complement. Infect. Immun. 76: 1774-1780.
10. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280:635-637.
11. Heininger U, et al. 1994. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306-309.
12. Hellwig SM, et al. 2001. Targeting to FcY{hooktop} receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J. Infect. Dis. 183:871-879.
13. Kurova N, Njamkepo E, Brun D, Tseneva G, Guiso N. 2010. Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Res. Microbiol. 161:810-815.
14. Lamberti Y, Perez Vidakovics ML, van der Pol LW, Rodriguez ME. 2008. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. Microb. Pathog. 44:501-511.
15. Lamberti YA, Hayes JA, Perez Vidakovics ML, Harvill ET, Rodriguez ME. 2010. Intracellular trafficking of Bordetella pertussis in human macrophages. Infect. Immun. 78:907-913.
16. Lavine J, Broutin H, Harvill ET, Bjornstad ON. 2010. Imperfect vaccineinduced immunity and whooping cough transmission to infants. Vaccine 29:11-16.
17. Liese JG, Renner C, Stojanov S, Belohradsky BH. 2003. Clinical and epidemiological picture of B. pertussis and B. parapertussis infections after introduction of acellular pertussis vaccines. Arch. Dis. Child. 88:684-687.
18. Long GH, Karanikas AT, Harvill ET, Read AF, Hudson PJ. 2010. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc. Biol. Sci. 277:2017-2025.
19. Maixnerova M. 2003. The 2001 serological survey in the Czech Republic-parapertussis. Cent. Eur. J. Public Health 11(Suppl):S23-S24.
20. Mañes S, del Real G, Martinez-AC. 2003. Pathogens: raft hijackers. Nat. Rev. Immunol. 3:557-568.
21. Matiasovic J, et al. 2011. Influence of the lipopolysaccharide structure of Salmonella enterica serovar Enteritidis on interactions with pig neutrophils. Vet. Microbiol. 150:167-172.
22. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382.
23. Moulder JW. 1985. Comparative biology of intracellular parasitism. Microbiol. Rev. 49:298-337.
24. Parkhill J, et al. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35:32-40.
25. Porte F, Naroeni A, Ouahrani-Bettache S, Liautard JP. 2003. Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect. Immun. 71:1481-1490.
26. Preston A, et al. 1999. Genetic basis for lipopolysaccharide O antigen biosynthesis in Bordetellae. Infect. Immun. 67:3763-3767.
27. Preston A, et al. 2006. Complete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides. J. Biol. Chem. 281: 18135-18144.
28. Repp R, et al. 1991. Neutrophils express the high affinity receptor for IgG (FcY{hooktop} RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885-889.
29. Rodal SK, et al. 1999. Extraction of cholesterol with methyl-betacyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10:961-974.
30. Rodriguez ME, et al. 2001. Fc receptor-mediated immunity against Bordetella pertussis. J. Immunol. 167:6545-6551.
31. Rodriguez ME, van der Pol WL, Sanders LA, van de Winkel JG. 1999. Crucial role of FcY{hooktop}RIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J. Infect. Dis. 179:423-433.
32. Schmitz FJ, Veldkamp KE, Van Kessel KP, Verhoef J, Van Strijp JA. 1997. Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst. J. Infect. Dis. 176:1531-1537.
33. Sturgill-Koszycki S, Schaible UE, Russell DG. 1996. Mycobacteriumcontaining phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15:6960-6968.
34. van den Herik-Oudijk IE, Capel PJA, van der Bruggen T, van de Winkel JGJ. 1995. Identification of signaling motifs within human Fc_RIIa and Fc_RIIb isoforms. Blood 85:2202-2211.
35. Watanabe M, Nagai M. 2004. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev. Anti Infect. Ther. 2:447-454.
36. Weingart CL, et al. 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67:4264-4267.
37. Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET. 2007. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussisinduced immunity. Infect. Immun. 75:4972-4979.
38. Wolfe DN, Kirimanjeswara GS, Harvill ET. 2005. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect. Immun. 73:6508-6513.
39. Zhang X, Goebel EM, Rodriguez ME, Preston A, Harvill ET. 2009. The Oantigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect. Immun. 77:5050-5058.
40. Zhang X, Rodriguez ME, Harvill ET. 2009. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One 4:e6989. doi: 10.1371/journal.pone.0006989.